Could new cancer targets change the outlook for personalised medicine? Kathleen Pritchard
Breast Cancer Risk Factors
Breast Cancer Symptoms
Breast Cancer Prognosis
Breast Cancer Staging
Breast Cancer Animated Infographic
The Changing Face of Cancer
Breast Cancer Statistics
Breast Cancer Backgrounder
Cancer statistics and incidence rates
Epidermal growth factor (EGF) receptors
Combined EGFR/HER1 and HER2 Inhibition
EGFR dysregulation and inhibition
Pathways in EGFR and HER signaling
A-Z Cancer Glossary
Source for healthcare professionals: www.inoncology.com* BIBF 1120, BIBW 2992 and BI 6727 are investigational compounds. Their safety and efficacy have not yet been fully established.